01 7Tecentriq
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 1,931
2018 Revenue in Millions : 795
Growth (%) : 143
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 3,051
2019 Revenue in Millions : 2,089
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 3,568
2020 Revenue in Millions : 2,902
Growth (%) : 21
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 4,063
2021 Revenue in Millions : 3,568
Growth (%) : 14
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 4,369
2022 Revenue in Millions : 4,063
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 516
2016 Revenue in Millions : 166
Growth (%) : 210
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 780
2017 Revenue in Millions : 492
Growth (%) : 59%
LOOKING FOR A SUPPLIER?
